Brain Natriuretic Peptide Blood Levels in the Differential Diagnosis of Dyspnea

Chronic obstructive pulmonary disease and pulmonary hypertension: brain natriuretic peptide as a marker of pulmonary hypertension

“…В ранее проведенных исследованиях показано увеличение концентрации BNP в плазме крови боль ных ЛГ, вызванной различными причинами [25][26][27][28], а также пациентов с систолической дисфункцией ПЖ [29], респираторной патологией [21,30]. В пред ставленном исследовании у больных ХОБЛ даже без признаков ЛГ концентрация BNP в плазме была вы ше по сравнению со значением этого показателя у лиц, не страдавших легочно сердечной патологи ей [31].…”

Canadian Cardiovascular Society Consensus Conference recommendations on heart failure update 2007: Prevention, management during intercurrent illness or acute decompensation, and use of biomarkers

“…Furthermore, LV function assessment may not be readily available, particularly in the urgent care settings. Patients with heart failure and preserved systolic LV function may have unremarkable echocardiographic findings (186,187). Indeed, many studies have now demonstrated that diagnosis of heart failure based on clinical assessment and standard testing may be inadequate (188)(189)(190).…”

The Diagnostic Value of B Natriuretic Peptide in Elderly Patients with Acute Dyspnea

“…Inappropriate emergency treatment occurred in 162 (32%) patients, and led to a higher mortality (25% versus 11%; p Ͻ 0.001), highlighting the importance of an early accurate treatment in the ED. Numerous studies have evaluated and validated both natriuretic peptides in the diagnosis of CHF in middle-aged patients with acute dyspneoa 26,[30][31][32][33][34][35][36][37][38][39][40][41] ( Tables 2 and 3). All studies used the same methodology, with a measurement of BNP at admission in dyspneic patients in the emergency room.…”